Ezose Sciences and Merck have signed a collaboration to look at changes in glycans, the sugar part of the protein-sugar complexes found on the surfaces of cells, in order to find potential biomarkers for diabetes. This project is an extension of an existing agreement, and uses Ezose's proprietary GlycanMap platform. Glycans, which make up the glycome (all the sugars found in the body, either alone or as part of other molecules), have many roles in health and disease and could have potential as targets for new therapeutics, as well as markers for diagnostics. Release (.pdf)